NFKB2's targets are enriched in the phenotype “chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)” (Supplemental Fig. S18B). The gene discussed is NFKB2; the disease is ankylosing spondylitis.